Research at the Institute of Biomedicine is divided into three functional units: 1) Infection and Immunity, 2) Integrative Physiology and Pharmacology and 3) Cancer research. Research at our Institute includes both biomedical basic research and translational research, and the unit division expresses our research priorities.
We encourage creative interdisciplinary combination of research topics via collaboration of the individual research groups and the three units. In addition, we collaborate locally with clinical researchers, with other institutes of our university and with the Åbo Akademi University. We are also widely networked with numerous national and international universities and public and private research institutes.
Research services
Recent publications
Tourism demand forecasting using stacking ensemble model with adaptive fuzzy combiner (2022)
Soft Computing - A Fusion of Foundations, Methodologies and Applications
(Refereed journal article or data article (A1))
Dubious effects of methadone as an “anticancer” drug on ovarian cancer cell-lines and patient-derived tumor-spheroids (2022)
Gynecologic Oncology
(Refereed journal article or data article (A1))
Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist (2022)
European Journal of Pharmacology
(Refereed journal article or data article (A1))
Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins (2022)
Bioinorganic Chemistry and Applications
(Refereed journal article or data article (A1))
Temporal changes in gastrointestinal fungi and the risk of autoimmunity during early childhood: the TEDDY study (2022)
Nature Communications
(Refereed journal article or data article (A1))
Recent doctoral dissertations
Tourism demand forecasting using stacking ensemble model with adaptive fuzzy combiner (2022)
Soft Computing - A Fusion of Foundations, Methodologies and Applications
(Refereed journal article or data article (A1))
Dubious effects of methadone as an “anticancer” drug on ovarian cancer cell-lines and patient-derived tumor-spheroids (2022)
Gynecologic Oncology
(Refereed journal article or data article (A1))
Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist (2022)
European Journal of Pharmacology
(Refereed journal article or data article (A1))
Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins (2022)
Bioinorganic Chemistry and Applications
(Refereed journal article or data article (A1))
Temporal changes in gastrointestinal fungi and the risk of autoimmunity during early childhood: the TEDDY study (2022)
Nature Communications
(Refereed journal article or data article (A1))